In acute myeloid leukaemia (AML), TRIB1 overexpression is associated with increased MEK1/ERK activity, which aids in promoting the characteristic enhancement of cell self-renewal, required for AML development [43]. Here, MAP2K1 is linked to acute myeloid leukemia.